The share allotment was made based on an approved resolution plan by the Hon'ble NCLT, Ahmedabad Bench through its order dated November 18, 2025. The breakdown of the allotment is as follows:
- 25,000 equity shares of ₹10 each allotted pursuant to reduction of capital through the approved resolution plan, bearing distinctive numbers 1 to 25000
- 475,000 equity shares of ₹10 each allotted on preferential basis:
- 425,000 equity shares to Successful Resolution Applicant (SRA/Promoter or Promoter Group)
- 50,000 equity shares to Secured Financial Creditor
- Bearing distinctive numbers 25001 to 500000
The company is currently in the process of executing corporate action with NSDL and CDSL and will be applying for trading approval shortly.
BSE's approval letter specifies additional documents required for trading permission, including: listing approval from NSE (if applicable), ISIN activation letters, auditor's certificate for book value per share, confirmation letters from depositories about share crediting, lock-in confirmation as per SEBI (ICDR) Regulations 2018, pre- and post-arrangement shareholding patterns in PDF and XBRL formats, old and new distinctive numbers, and details of any outstanding dues or SOP fines payment.
The communication was signed by Twinkle Bipinchandra Gajjar, Company Secretary and Compliance Officer (ICSI Membership No. A77101) on behalf of Dharti Proteins Limited.